Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 1-1 of 1 results.
{{ selectedCountPage }} items selected on this page,{{ selectedCountPage }} item selected on this page,{{ selectedCountTotal }} item in total{{ selectedCountTotal }} items in total
Study aim:
The effect of Trachyspermum copticum syrup on clinical presentation and respiratory infection of patients with COVID-19
Design:
This is a clinical trial. In this study, there are two groups of control ( who receive placebo ) and the intervention group (receiving Trachyspermum copticum syrup). The number of people in each group is thirty. The study is triple blind: participants, therapeutic staff, and statistical analyst of data and drugs are blinded.
Settings and conduct:
This study is carried out in Valiasr Hospital in Arak. This study is conducted by a researcher and a medical staff in a triple blind manner.
Participants/Inclusion and exclusion criteria:
Patients with COVID-19, written and informed satisfaction of patients
Intervention groups:
Patients with COVID-19 who have the criteria for entering the study are randomly divided into two groups then,Then for 2 weeks the patients in the intervention group will receive the Trachyspermum copticum syrup and the control group will receive placebo.
Main outcome variables:
Respiratory infection